Anthony Botti MD

Owner, LSG Infusion Services

Summary

Dr. Anthony Botti is a hematology specialist based in Livingston, NJ. He completed his residency in internal medicine at One Brooklyn Health System/Interfaith Medical Center following his medical degree from Universidad de Navarra Faculty of Medicine. He also holds a BA in Biology from Catholic University of America and an MS in Biomedical Sciences from Wagner College. Since 2011, he has served as Medical Director at LSG Infusion Services. Dr. Botti has expertise in myeloproliferative disorders, bone marrow failure syndromes, Hodgkin's lymphoma, myelodysplastic syndromes, and anemias. His published work includes studies on the JAK2V617F mutation and its connection to myeloproliferative malignancy. He has been recognized with the CMS Meaningful Use Stage 1 Certification and was named a Top MD by Consumers Checkbook.

LSG Infusion Services | Infusion North Jersey | 349 E. Northfield Ave, Suite 200

At LSG Infusion Services the emphasis is on personalized care and close coordination with your referring physician.

Hodgkin's lymphoma, Anemias, Myelodysplastic syndromes , Myeloproliferative disease, Bone marrow failure syndromes, Myeloproliferative disorders, Leukemia, Anemia

Long Island Coll Hosp1988
One Brooklyn Health System/Interfaith Medical CenterResidency, Internal Medicine, 1982 - 1985
Universidad de Navarra Faculty of MedicineClass of 1982
Wagner CollegeMS, Biomedical Sciences, 1978
Catholic University of AmericaBA, Biology, 1976

CMS Meaningful Use Stage 1 Certification ChartMaker Medical Suite EHR, STI Computer Services, Inc., 2012-2013
Top MD Consumers Checkbook

PubMed

6 citations
JAK2V617F mutation and myeloproliferative malignancy in a patient with Type 1 Gaucher disease.
Bryn D. Webb, Neal J. Weinreb, Anthony C. Botti, Brian Kirmse, Manisha Balwani
Blood Cells, Molecules & Diseases. 2011-01-15

Journal Articles

JAK2V617F Mutation and Myeloproliferative Malignancy in a Patient with Type I Gaucher Disease
Webb BD, Weinreb NJ, Botti AC, Kirmse BM, Balwani M, Blood Cells Mol Dis, 1/1/2011
The Molecular Biology of Acute Lymphoblastic Leukemia
Botti AC and Verma RS, Anti-Cancer Research, 1/1/1990
Lymphoma and the Acquired Immunodeficiency Syndrome: Cytogenetic and Molecular Correlates
Botti AC, Diamond GR and Verma RS, European Journal of Cancer and Clinical Oncology, 1/1/1988
Thrombotic Thrombocytopenic Purpura in a Patient Who Subsequently Developed the Acquired Immunodeficiency Syndrome
Botti AC, Hyde P, and Dipillo F, Annals of Internal Medicine, 1/1/1988
Clonal Expansion after Bone Marrow Transplantation in Patient with Chronic Myelogenous Leukemia
Macera MJ, Botti AC, Verma RS, Coleman M and Thomas ED, BLUT, 1/1/1988
A New Translocation Involving Chromosomes 8 and 9 in a So-called Ph-negative Chronic Myelogenous Leukemia
Botti AC, Macere MJ and Verma RS, Cancer Genetics and Cytogenetics, 1/1/1988
Join now to see all

Abstracts/Posters

Recombinant Human Interferon-alpha Safely Induces Remission in the Essential Thrombocytosis of the Elderly
Botti AC, Sangosse M, Abdelmessiah N and Ong E, 33rd Annual Meeting of the American Society of Hematology, Denver, Colorado, 1/1/1991
Fatal B-19 Parvovirus Infection in Two Patients Doubly Heterozygous for Hemoglobins 'S' and 'C'
Botti AC, Gascon P, Kanuga D and Nayak S, 32nd Annual Meeting of the American Society of Hematology, Boston, Massachussetts, 1/1/1990
Coexistent Hodgkin Lymphoma & Metastatic ca in a HIV(+) Patient
Botti AC and Kanuga D, 31st Annual Meeting of ASH, Atlanta, Georgia, 1/1/1989
Emergence of Complex Chromosomal Abnormalities after Bone Marrow Transplantation in a Patient with Chronic Myelogenous Leukemia
Botti AC, Macera MJ, Verma RS, Coleman M and Thomas ED, 39th Annual Meeting of the American Society of Human Genetics, New Orleans, Louisiana, 1/1/1988
Leukapheresis Safely Maintained Acceptable Peripheral Blood Counts in a Pregnant Woman with Chronic Myelogenous Leukemia
Botti AC, Kulpa J and Ramirez G, 29th Annual Meeting of the American Society of Hematology, Washington, D.C., 1/1/1987
Molecular Characterization of a Masked Ph-1 Chromosome with a Rare Translocation in Chronic Myelogenous Leukemia
Botti AC, Silver RT, Macera MJ and Verma RS, 29th Annual Meeting of the American Society of Hematology, Washington, D.C., 1/1/1987
Join now to see all